Therapeutic potential of histamine H3 receptor agonists and antagonists

Trends in Pharmacological Sciences

Volumn 19, Issue 5, 1998, Pages 177-184

  Leurs, Rob ^a   Blandina, Patrizio ^b   Tedford, Clark ^c   Timmerman, Henk ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b UNIVERSITY OF FLORENCE   (Italy)

^c GUILFORD PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXFENFLURAMINE; HISTAMINE H3 RECEPTOR AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST;

ATTENTION DEFICIT DISORDER; BINDING AFFINITY; COGNITION; DRUG POTENCY; EPILEPSY; FOOD AND DRUG ADMINISTRATION; LIGAND BINDING; MEMORY; NEUROLOGIC DISEASE; NEUROMODULATION; NEUROTRANSMISSION; OBESITY; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; TREATMENT INDICATION; WAKEFULNESS;

EID: 0031858013     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(98)01201-2     Document Type: Article

References (78)

1. Hill, S. J. et al. (1997) Pharmacol. Rev. 49, 253-278
2. Leurs, R., Smit, M. J. and Timmerman, H. (1995) Pharmacol. Ther. 66, 413-463
3. Ash, A. S. F. and Schild, H. O. (1966) Br. J. Pharmacol 27, 427-439
4. Black, J. W. et al. (1972) Nature 236, 385-390
5. Arrang, J. M., Garbarg, M. and Schwartz, J. C. (1983) Nature 302, 832-837
6. Watanabe, T. et al. (1984) Brain Res. 295, 13-25
7. Panula, P., Yang, H. Y. T. and Costa, E. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 2572-2576
8. Gothert, M. et al. (1995) Can. J. Physiol. Pharmacol. 73, 558-564
9. Bertaccini, G. and Coruzzi, G. (1995) Dig. Dis. Sci. 40, 2052-2063
10. Leurs, R., Vollinga, R. C. and Timmerman, H. (1995) Prog. Drug Res. 45, 107-165
11. Stark, H., Schlicker, E. and Schunack, W. (1996) Drugs Future 21, 507-520
12. Garbarg, M. et al. (1992) J. Pharmacol. Exp. Ther. 263, 304-310
13. Howson, W., Parsons, M. E., Raval, P. and Swayne, G. T. G. (1992) Bioorg. Med. Chem. Lett. 2, 77-78
14. Van der Goot, H., Schepers, M. J. P., Sterk, G. J. and Timmerman, H. (1992) Eur. J. Med. Chem. 27, 511-517
15. Vollinga, R. J. et al. (1994) J. Med. Chem. 37, 332-333
16. Rouleau, A. et al. (1997) J. Pharmacol. Exp. Ther. 281, 1085-1094
17. Krause, M. et al. (1995) J. Med. Chem. 38, 4070-4079
18. Krause, M. et al. (1996) Arch. Pharm. 329, 209-215
19. Arrang, J. M. et al. (1987) Nature 327, 117-123
20. Leurs, R. et al. (1995) Br. J. Pharmacol. 116, 2315-2321
21. Yamamoto, Y. et al. (1997) Methods Find. Exp. Clin. Pharmacol. 19, 289-298
22. Tedford, C. E. et al. (1997) Soc. Neurosci. Abstr. 23, 1784
23. Delaunois, A., Gustin, P., Garbarg, M. and Ansay, M. (1995) Eur. J. Pharmacol. 277, 243-250
24. Dimitriadou, V. et al. (1994) Clin. Sci. 87, 151-163
25. Ichinose, M., Belvisi, M. G. and Barnes, P. J. (1990) J. Appl. Physiol. 68, 21-25
26. Matsubara, T., Moskowitz, M. A. and Huang, Z. (1992) Eur. J. Pharmacol. 224, 145-150
27. Dimitriadou, V. et al. (1997) Neuroscience 77, 829-839
28. Imamura, M., Seyedi, N., Lander, H. M. and Levi, R. (1995) Circ. Res. 77, 206-210
29. Imamura, M., Lander, H. M. and Levi, R. (1996) Circ. Res. 78, 475-481
30. Imamura, M., Smith, N. C., Garbarg, M. and Levi, R. (1996) Circ. Res. 78, 863-869
31. Monti, J. M. (1993) Life Sci. 53, 1331-1338
32. Vanni-Mercier, G., Sakai, K. and Jouvet, M. (1984) C. R. Acad. Sci. 298, 195-200
33. Monnier, M., Sauer, R. and Hatt, A. M. (1970) Int. Rev. Neurobiol. 12, 265-305
34. Mochizuki, T. et al. (1992) Physiol. Behav. 51, 391-394
35. Orr, E. L. and Quay, W. B. (1975) Endocrinology 96, 941-945
36. Lin, J. S. et al. (1990) Brain Res. 523, 325-330
37. Monti, J. M., Jantos, H., Ponzoni, A. and Monti, D. (1996) Neuropsychopharmacology 15, 31-35
38. Sakai, N. et al. (1991) Life Sci. 48, 2397-2404
39. Mazurkiewicz-Kwilecki, I. M. and Nsonwah, S. (1989) Can. J. Physiol. Pharmacol. 67, 75-78
40. Panula, P. et al. (1998) Neuroscience 82, 993-997
41. Airaksinen, M. S. et al. (1991) Neuroscience 44, 465-481
42. Haas, H. L., Sergueeva, O. A., Vorobjev, V. S. and Sharonova, I. N. (1995) Behav. Brain Res. 66, 41-44
43. De Almeida, M. A. M. R. and Izquierdo, I. (1986) Arch. Int. Pharmacodyn. 283, 193-198
44. Kamei, C., Chung, Y. H. and Tasaka, K. (1990) Psychopharmacology 102, 312-318
45. Kamei, C. and Sakata, K. (1991) Jpn. J. Pharmacol. 57, 437-482
46. Pollard, H., Moreau, J., Arrang, J. M. and Schwartz, J. C. (1993) Neuroscience 52, 169-189
47. Blandina, P. et al. (1996) Br. J. Pharmacol. 119, 1656-1664
48. Prast, H., Argyriou, A. and Philippu, A. (1996) Brain Res. 734, 316-318
49. Smith, C. P. S., Hunter, A. J. and Bennett, G. W. (1994) Psychopharmacology 114, 651-656
50. Morris, R. G. M., Garrud, P., Rawlins, J. N. P. and O'Keefe, J. (1982) Nature 297, 681-683
51. Jäkälä, P. et al. (1993) Gen. Pharmacol. 24, 1141-1148
52. Meguro, K. I. et al. (1995) Pharmacol. Biochem. Behav. 50, 321-325
53. Miyazaki, S., Imaizumi, M. and Onodera, K. (1995) Life Sci. 57, 2137-2144
54. Miyazaki, S., Onodera, K., Imaizumi, M. and Timmerman, H. (1997) Life Sci. 61, 355-361
55. Oades, R. D. (1987) Prog. Neurobiol. 29, 365-391
56. Arnsten, A. F. T., Steere, J. C. and Hunt, R. D. (1996) Arch. Gen. Psychiatry 53, 448-455
57. Shaywitz, B. A. et al. (1984) Psychopharmacology 82, 73-77
58. Dumery, V. and Blozovski, D. (1987) Exp. Brain Res. 67, 61-69
59. Tedford, C. E. et al. (1995) J. Pharmacol. Exp. Ther. 275, 598-604
60. Tedford, C. E. et al. (1996) Soc. Neurosci. Abstr. 22, 22
61. 3 Receptor (Leurs, R. and Timmerman, H., eds), Elsevier (in press)
62. Churchill, J. A. and Gammon,G. D. (1949) J. Am. Med. Assoc. 141, 18-21
63. Wyngaarden, J. B. and Seevers, M. B. (1951) J. Am. Med. Assoc. 145, 277-282
64. Yokoyama, H. and Iinuma, K. (1996) CNS Drugs 5, 321-330
65. Iinuma, K. et al. (1993) Lancet 341, 238
66. Murakami, K. et al. (1995) Methods Find. Exp. Clin. Pharmacol. 17, 70-73
67. Yokoyama, H.,Onodera, K., Iinuma, K. and Watanabe, T. (1993) Eur. J. Pharmacol. 234, 129-133
68. Yokoyama, H. et al. (1994) Eur. J. Pharmacol. 260, 23-28
69. Goldstein, D. G. and Frautmann, M. E. (1997) Emerging Drugs 2, 1-27
70. Sakata, T. (1995) Obes. Res. 3, S541-S548
71. Merali, Z. and Bamks, K. (1994) Am. J. Physiol. 36, R1589-R1595
72. Lutz, T. A., DelPrete, E., Walzer, B. and Scharrer, E. (1996) Peptides 17, 1317-1322
73. Laitinen, K. S. M., Tuomisto, L. and Laitinen, J. T. (1995) Eur. J. Pharmacol. 285, 159-164
74. Machidori, H. et al. (1992) Brain Res. 590, 180-186
75. Morisset, S., Traiffort, E. and Schwartz, J. C. (1996) Eur. J. Pharmacol. 315, R1-R2
76. Cumming, P., Reiner, P. B. and Vincent, S. R. (1990) Biochem. Pharmacol. 40, 1345-1350
77. Korte, A. et al. (1990) Biochem. Biophys. Res. Commun. 168, 979-986
78. Soejensen, P. et al. (1993) Neuroendocrinology 57, 532-540